Lyophilized oral sustained release polymeric nanoparticles of nateglinide

AAPS PharmSciTech

Volumn 14, Issue 1, 2013, Pages 78-85

  Kaleemuddin, Mohammad ^a   Srinivas, Prathima ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

drug encapsulation efficiency; nanoparticles; poly caprolactone (PCL); probe sonication

Indexed keywords

GLUCOSE; NANOPARTICLE; NATEGLINIDE; POLYCAPROLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SOLUBILITY; EVAPORATION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TABLET; ULTRASOUND;

ADMINISTRATION, ORAL; ANIMALS; CYCLOHEXANES; FREEZE DRYING; HYPOGLYCEMIC AGENTS; MALE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PHENYLALANINE; POLYMERS; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84878590904     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9887-z     Document Type: Article

References (15)

1. Krishna Reddy NV, Phani RSC, Rameshraju R. Validated RP-HPLC method for the estimation of nateglinide in formulation. Int J Res Pharm Chem. 2011;1(1):46-9.
2. McLeod JF. Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent. Clin Pharmacokinet. 2004;43:97-120.
3. Abdelwaheda W, Degoberta G, Stainmesseb S, Fessia H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58:1688-713.
4. Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine Nanotechnol Biol Med. 2006;2:8-21.
5. Rieux Ad, Fievez V, Garinot M, Schneider Y-J, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116:1-27.
6. Galindo-Rodriguez SA, Allemann E, Fessi H, Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit Rev Ther Drug Carrier Syst. 2005;22:419-64.
7. Sankalia JM, Sankalia MG, Sutariya VB, Mashru RC. Nateglinide quantification in rabbit plasma by HPLC: optimization and application to pharmacokinetic study. J Pharm Biomed Anal. 2007;44:196-204.
8. Kim BK, Hwang SJ, Park JB, Park HJ. Characteristics of felodipine-located poly(ε-caprolactone) microspheres. J Microencapsul. 2005;22:193-203.
9. Konan Y, Gurny R, Allemann E. Preparation and characterization of sterile and freeze dried sub-200 nm nanoparticles. Int J Pharm. 2002;233:239-52.
10. Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 2005;290:137-44.
11. Byuna Y, et al. Formulation and characterization of α-tocopherol loaded poly ε-caprolactone (PCL) nanoparticles. LWT Food Sci Technol. 2011;44:24-8.
12. Dhanalekshmi UM, Poovi G, Narra K, Neelakanta Reddy P. In vitro characterization and in vivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles. Int J Pharm. 2010;396:194-203.
13. Damgé C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release. 2007;117:163-70.
14. Cuia F, Shia K, Zhanga L, Taoa A, Kawashima Y. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release. 2006;114:242-50.
15. Thirupathi Reddy G, Ravi Kumar B, Krishna Mohan G, Ramesh M. Anithyperglycemic activity of Momordica dioica fruits in alloxan-induced diabetic rats. Asian J Pharmacodyn Pharmacokinet. 2006;6:327-9.